Clover Health stock draws focus after Q3 profit, guidance lift

Published on 11/05/2026 at 01:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Clover Health stock follows a profitable third quarter and higher 2026 targets. Medicare Advantage growth and a five-star PPO rating shape the outlook.

Third-quarter results reshape outlook

Clover Health returned to quarterly GAAP profitability as revenue and membership expanded year over year.
Management raised the lower end of its full-year 2026 revenue, profit, gross-profit and Adjusted EBITDA ranges.
A five-star PPO rating for Payment Year 2028 supports the companys Medicare Advantage positioning.

CLOV, US18914F1030, Illustration mit AI erstellt.

Clover Health reported third-quarter results after the market close on Wednesday, November 4, with quarterly GAAP net income of USD 6.4 million compared with a USD 24.4 million loss a year earlier. The release, carried by Yahoo Finance, showed revenue of USD 759.3 million, up 52.9 percent from the third quarter of 2025.

Profitability and membership expand

Medicare Advantage membership reached 158,907 at September 30, an increase of 45 percent from a year earlier. Consolidated gross profit rose 77.3 percent to USD 129.8 million, while Adjusted EBITDA increased to USD 16.1 million from USD 2.1 million. The Insurance Benefits Expense Ratio improved to 91.1 percent from 93.5 percent.

For the first nine months, Clover Health reported GAAP net income of USD 61.8 million, compared with a USD 36.2 million loss in the same period of 2025. The company said it remains on track for its first full year of GAAP profitability.

Guidance moves higher

Clover Health raised the lower end of each key 2026 target. Revenue is now expected between USD 2.97 billion and USD 3.00 billion, compared with a previous floor of USD 2.92 billion. The new ranges also call for GAAP net income of USD 25 million to USD 35 million, consolidated gross profit of USD 540 million to USD 555 million and Adjusted EBITDA of USD 75 million to USD 85 million.

Management said enrollment trends for the 2027 Annual Enrollment Period were developing well. It also said roughly 98 percent of current members are enrolled in the companys flagship PPO, which received a five-star rating for Payment Year 2028.

Late-session quote remains in focus

Clover Health stock traded at 4.13 euros on Lang & Schwarz at 11:00 p.m. CET on Wednesday, November 4, 2026.

Clover Healths operating model

Clover Health is a US Medicare Advantage insurer and physician enablement technology company. Its Clover Assistant platform aggregates patient data to support clinical decisions, while the company offers PPO and HMO plans and extends related technology to providers through Counterpart Health. The business is headquartered in the United States and focuses on seniors eligible for Medicare, with a particular emphasis on wide-network PPO plans.